| THBS1 |
THBS1, TSP, TSP1: Thrombospondin-1 precursor |
TPBG |
TPBG, 5T4: Trophoblast glycoprotein precursor |
0.435 |
Evidence |
|
| CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
FGL2 |
FGL2: Fibroleukin precursor |
0.435 |
Evidence |
|
| ASGR1 |
ASGR1: Asialoglycoprotein receptor 1 |
C6 |
C6: Complement component C6 precursor |
0.435 |
Evidence |
|
| ASGR1 |
ASGR1: Asialoglycoprotein receptor 1 |
C8B |
C8B: Complement component C8 beta chain precursor |
0.435 |
Evidence |
|
| ITGAV |
ITGAV, MSK8, VNRA: Integrin alpha-V precursor |
LAMB1 |
LAMB1: Laminin subunit beta-1 precursor |
0.435 |
Evidence |
|
| ITGAV |
ITGAV, MSK8, VNRA: Integrin alpha-V precursor |
LAMC1 |
LAMC1, LAMB2: Laminin subunit gamma-1 precursor |
0.435 |
Evidence |
|
| SSB |
SSB: Lupus La protein |
G3BP |
G3BP1, G3BP: Ras GTPase-activating protein-binding protein 1 |
0.435 |
Evidence |
|
| EIF2S1 |
EIF2S1, EIF2A: Eukaryotic translation initiation factor 2 subunit 1 |
FXR1 |
FXR1: Fragile X mental retardation syndrome-related protein 1 |
0.435 |
Evidence |
|
| ITGB2 |
ITGB2, CD18, MFI7: Integrin beta-2 precursor |
JAK1 |
|
0.435 |
Evidence |
|
| ITGB2 |
ITGB2, CD18, MFI7: Integrin beta-2 precursor |
PSCD4 |
PSCD4, CYT4: Cytohesin-4 |
0.435 |
Evidence |
|
| ITGB2 |
ITGB2, CD18, MFI7: Integrin beta-2 precursor |
SERPINB1 |
SERPINB1, ELANH2, MNEI, PI2: Leukocyte elastase inhibitor |
0.435 |
Evidence |
|
| ITGB2 |
ITGB2, CD18, MFI7: Integrin beta-2 precursor |
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
0.435 |
Evidence |
|
| TP53 |
TP53, P53: Cellular tumor antigen p53 |
PSMD11 |
PSMD11: 26S proteasome non-ATPase regulatory subunit 11 |
0.435 |
Evidence |
|
| TP53 |
TP53, P53: Cellular tumor antigen p53 |
EIF3S8 |
EIF3S8: Eukaryotic translation initiation factor 3 subunit 8 |
0.435 |
Evidence |
|
| PLG |
PLG: Plasminogen precursor |
ASGR1 |
ASGR1: Asialoglycoprotein receptor 1 |
0.435 |
Evidence |
|
| EIF3S4 |
EIF3S4: Eukaryotic translation initiation factor 3 subunit 4 |
PCBP1 |
PCBP1: Poly(rC)-binding protein 1 |
0.435 |
Evidence |
|
| MYCBP2 |
MYCBP2, KIAA0916, PAM: Probable E3 ubiquitin-protein ligase MYCBP2 |
USP34 |
USP34, KIAA0570, KIAA0729: Ubiquitin carboxyl-terminal hydrolase 34 |
0.435 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
0.435 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
ITGB2 |
ITGB2, CD18, MFI7: Integrin beta-2 precursor |
0.435 |
Evidence |
|
| SYNCRIP |
SYNCRIP, HNRPQ, NSAP1: Heterogeneous nuclear ribonucleoprotein Q |
USP10 |
USP10, KIAA0190: Ubiquitin carboxyl-terminal hydrolase 10 |
0.435 |
Evidence |
|
| SYNCRIP |
SYNCRIP, HNRPQ, NSAP1: Heterogeneous nuclear ribonucleoprotein Q |
FXR1 |
FXR1: Fragile X mental retardation syndrome-related protein 1 |
0.435 |
Evidence |
|
| BTAF1 |
BTAF1, TAF172: TATA-binding protein-associated factor 172 |
MAPRE1 |
MAPRE1: Microtubule-associated protein RP/EB family member 1 |
0.435 |
Evidence |
|
| BTAF1 |
BTAF1, TAF172: TATA-binding protein-associated factor 172 |
PPIA |
PPIA, CYPA: Peptidyl-prolyl cis-trans isomerase A |
0.435 |
Evidence |
|
| XPO1 |
XPO1, CRM1: Exportin-1 |
VDP |
DKFZp451D234: Putative uncharacterized protein DKFZp451D234 |
0.435 |
Evidence |
|
| XPO1 |
XPO1, CRM1: Exportin-1 |
SPEN |
SPEN, KIAA0929, MINT, SHARP: Msx2-interacting protein |
0.435 |
Evidence |
|